Published in

American Chemical Society, Journal of Chemical Information and Modeling, 3(56), p. 563-570, 2016

DOI: 10.1021/acs.jcim.5b00705

Links

Tools

Export citation

Search in Google Scholar

Interplay Between Two Allosteric Sites and Their Influence on Agonist Binding in Human μ Opioid Receptor

Journal article published in 2016 by Damian Bartuzi ORCID, Agnieszka A. Kaczor, Dariusz Matosiuk
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Allostery is a widespread mechanism that allows for precise protein tuning. Its underlying mechanisms are elusive, particularly when there are multiple allosteric sites at the protein. This concerns also G-protein-coupled receptors (GPCRs), which are targets for vast part of currently used drugs. To address this issue, we performed molecular dynamics simulations of a GPCR - human μ opioid receptor (MOR) in native-like environment, with full agonist (R)-methadone, Na(+) ions and a positive modulator (PAM) BMS986122 in various configurations. We found that MOR's 7th transmembrane helix (TM VII) is central for allosteric signal transmission, and modulators affect its bending and rotation. The PAM stabilizes favorable agonist interaction, while Na(+) tends to disrupt agonist binding. We identified two residues involved in allosteric signal transmission - Trp 7.35 at the top and Tyr 7.53 at the bottom of TM VII.